Skip to main content
TG THERAPEUTICS, INC. logo

TG THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · TGTX ISIN · US88322Q1085 LEI · 529900X21UKABN9NJ529 US Manufacturing
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2020-11-09 Capital/Financing Update
Country US United States of America
Listing US TGTX

About TG THERAPEUTICS, INC.

https://www.tgtherapeutics.com/

TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. The company's primary area of focus is autoimmune diseases, particularly multiple sclerosis (MS). Its lead commercial product is BRIUMVI® (ublituximab), an approved therapy for adults with relapsing forms of MS. TG Therapeutics also develops a pipeline of potential therapies for B-cell malignancies and other autoimmune conditions, including investigational CAR-T cell therapies.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 9, 2020, by TG Therapeutics, Inc. It announces the launch of an 'at the market offering' of common stock pursuant to a previously filed Sales Agreement. The document includes details about the offering, the agents involved, and references to exhibits such as the Sales Agreement and legal opinion. There are no financial statements or detailed financial results presented, nor is this a full annual or quarterly report. The content focuses on a capital raising activity through an equity offering. According to the filing definitions, updates on company fundraising or financing activities fall under 'Capital/Financing Update' (CAP). Therefore, this document is best classified as a Capital/Financing Update (CAP). The document length is sufficient and the content is substantive, not merely an announcement of a report publication or a certification, so it is not RPA or RNS. Confidence is high given the clear description of the offering and the nature of the filing.
2020-11-09 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a common stock offering of up to $400 million. It includes detailed information about the terms of the offering, risk factors, use of proceeds, plan of distribution, and legal matters. The document is clearly a securities offering document, specifically a prospectus supplement and accompanying prospectus, which are used to inform investors about a capital raising event. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive information about the offering, not just an announcement or a brief notice. Therefore, the correct classification is CAP with high confidence.
2020-11-09 English
10-Q
Interim / Quarterly Report Q3 2020
2020-11-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is announcing a press release about data selected for presentation at a conference (the 62nd American Society of Hematology Annual Meeting). There are no financial statements or detailed financial data included, only a reference to a press release as an exhibit. The document length is short (3136 characters), and it primarily serves as an announcement of an event and a press release filing. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories and includes current reports like Form 8-K that announce events but do not contain full financial reports or detailed presentations.
2020-11-05 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-09-11 English
10-Q
Interim / Quarterly Report Q2 2020
2020-08-10 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.